期刊文献+

益气温阳活血方对慢性心力衰竭患者心室重塑相关因子的影响 被引量:6

Study on the effects of decoction of yiqiwenyanghuoxue on MMPs and cytokines in the patiens with cardiac remodeling
下载PDF
导出
摘要 目的观察益气温阳活血方对慢性心力衰竭心室重塑患者血清金属基质蛋白酶2、9(MMP-2、MMP-9)、金属基质蛋白酶抑制物1、2(TIMP-1、TIMP-2)、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)的影响。方法将慢性心衰患者126例随机分为两组,两组均按慢性心力衰竭治疗指南给予常规治疗,治疗组加服益气温阳活血方。两组治疗前后分别以心脏超声检查患者左心室收缩末径(LVESD),舒张末径(LVEDD)和左心室射血分数(LVEF%),以及酶联免疫吸附法(ELISA)检测血清MMP-2、MMP-9、TIMP-1、TIMP-2、TNF-α、IL-6含量。结果3个月后治疗组LVESD、LVEDD明显缩小,LVEF则明显提高,与治疗前比较,差异有显著性意义(P<0.05)。3个月后患者血清MMP-2、MMP-9、TNF-α、IL-6明显降低,而TIMP-1、TIMP-2、则明显升高,与对照组比较,差异有显著性(P<0.05)。结论益气温阳活血方可降低MMP-2、MMP-9、TNF-α、IL-6含量,升高TIMP-1、TIMP-2含量,防止心室重塑。 Objective To investigate effects of decoction of yiqiwenyanghuoxue on MMPs and in- flammatory cytokines in the patiens with cardiac remodeling. Methods 126 patients with chronic heart failure were randomly divided into two groups which were the control group and treatment group. The control group were given conventional treatment, while the treatment group were decoction of yiqiwe- nyanghuoxue combined routine therapy, then heart function parameters of ultrasonic cradiography and MMP-2, MMP-9,TIMP-1,TIMP-2, TNF-a, and IL-6 were measured before and after treatment. Re- sults After 3 months, LVEDD and LVESD were decreased, while LVEF increased significantly than those of before therapy (P〈~0. 05) . MMP-2, MMP-9, TNF-a, and IL-6 were decreased, whiile TIMP-1 and TIMP-2 increased significantly than those of the control group(P^0.05). Conclusion De- coction of yiqiwenyanghuoxue can prevent cardiac remodeling through regulating MMP-2, MMP-9, TIMP-1, TIMP-2,TNF-a, IL-6 levels.
出处 《贵州医药》 CAS 2012年第11期976-978,共3页 Guizhou Medical Journal
基金 贵阳中医学院院内课题(2010) 黔中医药发Qzyy2010-43
关键词 心室重塑 金属基质蛋白 炎症细胞因子 益气温阳活血方 Cardiac remodeling MMPs Inflammatory cytokines Decoction of yiqiwen- yang huoxue
  • 相关文献

参考文献6

二级参考文献90

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2王琦,柳兢,姚凤臣.替米沙坦对心肌梗死大鼠心肌重构基质金属蛋白酶表达水平的影响[J].山西医药杂志,2007,36(5):406-409. 被引量:8
  • 3Sato M, Hutchinson DS, Bengtsson T, et al. Functional domains of the mouse β3-Adrenoeeptor associated with differential G-protein coupling. J Pharmacol Exp Ther, 2005, 315(12) :1354-1361.
  • 4Rozec .B, Gauthier C. β3-adrenoceptors in the cardiovascular system: putative pathological role in human pathologies. Pharmacol Ther, 2006, 111:652-673.
  • 5Michel MC, Teitsma CA, Vrydag W, et al. β3-Adrenergic receptor gene polymorphisms: comparison of human with chimpanzee and Rhesus macaque. FASEB J, 2008, 22(3) :1134. 3.
  • 6Brodde OE, Bruck H, Eeinweber K. Cardiac adrenoceptors: physiological and pathophysiological relevance. J Pharm Sci, 2006, 100: 323-337.
  • 7Rouget C, Breuiller-Fouche M, Mercier FJ, et al. The human nearterm myometrial β3-adrenoceptor but not the β2-adrenoceptor is resistant to desensitisation after sustained agonist stimulation. Br J Pharmacol, 2004, 141(5) : 831-841.
  • 8Baker JG. The selectivity of β-adrenoceptor antagonists at the β1, β2 and β3 adrenoceptors. Br J Pharmacol, 2005,144:317-322.
  • 9Pavoine C, Defer N. The cardiac β2-adrenergic signalling: a new role for the cPLA2. Cell Signal, 2005, 17(2) : 141-152.
  • 10Zhang ZS, Cheng HJ, Onishi K, et al. Enhanced inhibition of L- type Ca2 + current by β3-adrenergic stimulation in failing rat heart. J Pharmacol Exp Ther, 2005, 315(12) : 1203-1211.

共引文献3714

同被引文献89

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部